Target intelligence / Profile preview

Nicotinamide phosphoribosyltransferase pseudogene 2 (NAMPTP2)

Target
NAMPTP2
Molecular classification
Pseudogene
01

Overview

Nicotinamide phosphoribosyltransferase pseudogene 2 (NAMPTP2) is a nonfunctional genomic segment in humans, categorized as a pseudogene. Pseudogenes such as NAMPTP2 do not produce a functional protein but may share high sequence similarity with their related coding genes. They can be formed from duplication, mutation, or retrotransposition events. While some pseudogenes may acquire regulatory roles affecting gene networks, there is no evidence or data indicating a direct biological function, disease association, or therapeutic relevance for NAMPTP2. Pseudogenes are usually not considered valid drug or therapeutic targets as they do not encode functional proteins. Some pseudogenes may be implicated in regulatory gene networks or disease as RNA molecules, but no such evidence exists for NAMPTP2 specifically. Lack of information about biomarker utility, drug interactions, or safety concerns is due to its classification as a pseudogene and non-target status.

Other names
NAMPTP2

Beyond the preview

Go deeper on Nicotinamide phosphoribosyltransferase pseudogene 2 (NAMPTP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinamide phosphoribosyltransferase pseudogene 2 (NAMPTP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call